COGNIFAST 90MG contains Cerebroprotein hydrolysate which belongs to the group of medicine called neurotrophic agents. It is used to manage traumatic brain injury, ischemic stroke, vascular dementia and Alzheimer's disease. Cerebroprotein hydrolysate is a unique drug with small neurological peptides produced by standardized enzymatic breakdown of lipid-free porcine brain proteins. It contains numerous neurotrophic factors which enhances neurogenesis, neuronal survival, neuromodulatory action, neuronal repair and has neuroimmunotrophic actions. It reduces excitotoxic damage and offers protection against ischemic and neurotoxic lesions.

Take this medicine as directed by your physician. Your doctor will decide the correct dose and duration for you depending upon your condition. Do not take this medicine, if you have any pre-existing epileptic conditions such as status epilepticus or grand mal seizure, as this medicine may increase the frequency of seizure attacks. Before taking this medicine, inform your doctor if you have any renal insufficiency or renal dysfunction. COGNIFAST 90MG should be used in pregnant or breastfeeding women only if it is clearly necessary due to lack of data on human study. Discuss the risks and benefits with your doctor. The most common side effects of taking this medicine are nausea, vomiting, indigestion, tremor or flu-like symptoms. Contact your doctor if any of these symptom bothers you. Avoid concomitant use of this medicine with antidepressants, as they may increase the risk of side effects.